Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNPH1 | O43598 | 9/20 | 0.75 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.75 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.75 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.73 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.73 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.73 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.73 |
| ▸ | LDHA | P00338 | 1/20 | 0.73 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.73 |
| ▸ | FBP1 | P09467 | 1/20 | 0.73 |
| ▸ | SRC | P12931 | 1/20 | 0.73 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.73 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.73 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.73 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.73 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.73 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.73 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.73 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4307198 | 1.00 | DNPH1 (0.75) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL26067680 | 1.00 | DNPH1 (0.75) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL14358309 | 0.99 | DNPH1 (0.74) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL26067558 | 0.93 | DNPH1 (0.66) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL26067580 | 0.93 | DNPH1 (0.66) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL31396265 | 0.92 | P2RX3 (0.77) | DNPH1TAS1R3TAS1R1P2RY1TRPM2 | |
| SCHEMBL14358316 | 0.92 | ADORA1 (0.77) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL18574268 | 0.92 | P2RY1 (0.66) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL14929511 | 0.92 | P2RY1 (0.66) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 | |
| SCHEMBL14946362 | 0.92 | P2RY1 (0.66) | DNPH1TAS1R3TAS1R1ADORA1P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120064427-A | Method and analysis system for detecting brain nucleic acid hydrolysate spatial distribution based on mass spectrum imaging | 北京脑科学与类脑研究所 | 2025-05-30 | — | — | CN | claimed |
| CN-122017074-A | Method for detecting phosphate-containing metabolite and application thereof | 澳门科技大学 | 2026-05-12 | — | — | CN | disclosed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| CN-120064427-A | Method and analysis system for detecting brain nucleic acid hydrolysate spatial distribution based on mass spectrum imaging | 北京脑科学与类脑研究所 | 2025-05-30 | — | — | CN | disclosed |
| CN-118103711-A | Single molecule identification with reactive heterogeneous nanopores | 南京大学 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023084013-A1 | COMPOSITIONS COMPRISING MODIFIED RNA ENCODING VEGF-A AND METHODS OF USE | MODERNATX, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023061985-A2 | COMPOSITIONS COMPRISING MODIFIED RNA ENCODING VEGF-A AND METHODS OF USE | MODERNATX, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2023014974-A1 | DOUBLE STRANDED MRNA VACCINES | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2023-02-09 | — | — | WO | disclosed |
| CN-112921014-B | T7RNA polymerase mutant, mRNA, gene, expression vector and cell | 左炽健 | 2023-01-06 | — | — | CN | disclosed |
| WO-2022241165-A2 | COMPOSITIONS AND METHODS OF USE FOR MUTATED HOTAIR IN THE TREATMENT OF CANCERS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2022-11-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | DNPH1 2227/4885TAS1R3 3879/4885TAS1R1 4321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.